SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy
BACKGROUND: Dysregulated metabolism of bioactive sphingolipids, including ceramides and sphingosine-1-phosphate, has been implicated in cardiovascular disease, although the specific species, disease